2023. Real-world effectiveness of ixekizumab in mild, moderate, and severe psoriasis: The patient perspective. SKIN The Journal of Cutaneous Medicine. 7, 3 (May 2023), s202. DOI:https://doi.org/10.25251/skin.7.supp.202.